With data as of April 9, 2025, we examine if Bristol-Myers Squibb Company(BMY) is consistently building momentum based on ...

The leadership team is focused on building impactful collaborations ... Intercon Region for Bristol Myers Squibb. "This region represents an important part of our international strategy, and ...

While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...

Bristol Myers Squibb announced that the European Commission (EC ... thousands of patients can be treated with cell therapy’s transformational potential. The building blocks to realize this ambition—a ...

Bristol-Myers Squibb Co. has announced it will acquire ... the portfolio we have built to help patients with diabetes by building on the success Amylin has had with its GLP-1 franchise.

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

A year ago, our company made a bold move. We put up a million dollars in prize money for any of our team members—no matter ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...

U.S. stocks are flying higher after President Donald Trump announced a drop in some of his tariffs, except for China.